Literature DB >> 8405040

Human CD38 is associated to distinct molecules which mediate transmembrane signaling in different lineages.

A Funaro1, L B De Monte, U Dianzani, M Forni, F Malavasi.   

Abstract

The CD38 antigen displays restricted functional associations with surface molecules involved in immune system and complement. Capping of the CD38 molecule in normal or neoplastic T cells is followed by rapid and specific co-modulation of the CD3-T cell receptor (TcR) complex. In normal and tumor cells of B lineage, CD38 was found to be also associated with surface Ig (sIg) and with the complement receptor 2 (CR2)/CD19 complex. The CD38 molecule expressed by purified natural killer cells displayed an association with the low affinity IgG Fc receptor (Fc gamma RIII) CD16. These observations suggest that specialized areas in the plasma membrane contain co-modulating structures, including different receptors involved in the transduction of extracellular signals. We propose a model whereby TcR, CR2 and CD16 are ligand binding structures in their respective lineages, while CD38 is a molecule involved in the intracellular transduction of the signals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8405040     DOI: 10.1002/eji.1830231005

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.

Authors:  P Bürgisser; C Hammann; D Kaufmann; M Battegay; O T Rutschmann
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

2.  IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-alpha and DTIC.

Authors:  Gordana Konjević; Viktor Jović; Vladimir Jurisić; Sinisa Radulović; Svetislav Jelić; Ivan Spuzić
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes.

Authors:  Nicola Lo Buono; Rossella Parrotta; Simona Morone; Paola Bovino; Giulia Nacci; Erika Ortolan; Alberto L Horenstein; Alona Inzhutova; Enza Ferrero; Ada Funaro
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

4.  Dendritic cells and follicular dendritic cells express a novel ligand for CD38 which influences their maturation and antibody responses.

Authors:  Michelle N Wykes; Lynette Beattie; Gordon G Macpherson; Derek N Hart
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

Review 5.  CD38 autoimmunity: recent advances and relevance to human diabetes.

Authors:  A Antonelli; E Ferrannini
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

6.  ATRA-induced HL-60 myeloid leukemia cell differentiation depends on the CD38 cytosolic tail needed for membrane localization, but CD38 enzymatic activity is unnecessary.

Authors:  Johanna Congleton; Hong Jiang; Fabio Malavasi; Hening Lin; Andrew Yen
Journal:  Exp Cell Res       Date:  2010-12-13       Impact factor: 3.905

7.  CD62L(neg)CD38⁺ expression on circulating CD4⁺ T cells identifies mucosally differentiated cells in protein fed mice and in human celiac disease patients and controls.

Authors:  M Fleur du Pré; Lisette A van Berkel; Melinda Ráki; Marieke A van Leeuwen; Lilian F de Ruiter; Femke Broere; Mariëtte N D Ter Borg; Frances E Lund; Johanna C Escher; Knut E A Lundin; Ludvig M Sollid; Georg Kraal; Edward E S Nieuwenhuis; Janneke N Samsom
Journal:  Am J Gastroenterol       Date:  2011-03-08       Impact factor: 10.864

8.  A monoclonal antibody against a murine CD38 homologue delivers a signal to B cells for prolongation of survival and protection against apoptosis in vitro: unresponsiveness of X-linked immunodeficient B cells.

Authors:  Y Yamashita; K Miyake; Y Kikuchi; K Takatsu; S Noda; A Kosugi; M Kimoto
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Daratumumab induces CD38 internalization and impairs myeloma cell adhesion.

Authors:  Jayeeta Ghose; Domenico Viola; Cesar Terrazas; Enrico Caserta; Estelle Troadec; Jihane Khalife; Emine Gulsen Gunes; James Sanchez; Tinisha McDonald; Guido Marcucci; Balveen Kaur; Michael Rosenzweig; Jonathan Keats; Steven Rosen; Amrita Krishnan; Abhay R Satoskar; Craig C Hofmeister; Flavia Pichiorri
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

10.  Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells.

Authors:  Aneel Paulus; Alak Manna; Sharoon Akhtar; Shumail M Paulus; Mayank Sharma; Marie V Coignet; Liuyan Jiang; Vivek Roy; Thomas E Witzig; Stephen M Ansell; John Allan; Richard Furman; Sonikpreet Aulakh; Rami Manochakian; Sikander Ailawadhi; Asher A Chanan-Khan; Taimur Sher
Journal:  Br J Haematol       Date:  2018-08-06       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.